Orthofix Medical, Inc. engages in the provision of medical devices. The company is headquartered in Lewisville, Texas and currently employs 1,616 full-time employees. The firm offers a portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics and enabling technologies, including the 7D FLASH navigation system. The Company’s Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. The segment provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. The company offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Orthopedics segment offers products and solutions for limb deformity correction and complex limb reconstruction with a focus on use in trauma, adult and pediatric limb reconstruction, and foot and ankle procedures.
최신 재무제표(Form-10K)에 따르면, Orthofix Medical Inc의 총 자산은 $850이며, 순손실입니다.
OFIX의 주요 재무 비율은 무엇인가요?
Orthofix Medical Inc의 유동비율은 2.12이고, 순이익률은 -11.19, 주당 매출은 $20.75입니다.
Orthofix Medical Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Orthofix Medical Inc 주요 수익원은 Spinal Implants, Biologics, and Enabling Technologies이며, 최신 수익 발표에서 수익은 418,789,000입니다. 지역별로는 United States이 Orthofix Medical Inc의 주요 시장이며, 수익은 620,829,000입니다.
Orthofix Medical Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Orthofix Medical Inc의 순손실은 $-92입니다.